As the development of an effective treatment for the new coronavirus infection (COVID-19) is urgent, on October 1, 2021, the pharmaceutical company Merck conducted a phase 3 clinical trial of the oral ...

The world could soon be armed with another tool to fight the coronavirus pandemic: a twice-daily pill that has been shown to reduce the risk of hospitalization and death among people infected with the ...

What is molnupiravir and how does it stop COVID? The anti-COVID pill by American multinational pharmaceutical company Merck is designed to stop the coronavirus from replicating by inserting errors ...

Covid-19 pill: What is molnupiravir? And how does it work?Covid-19 pill: What is molnupiravir? And how does it work?

Merck and Ridgeback Biotherapeutics’ antiviral of the moment, molnupiravir, appears likely to become the first oral treatment approved for Covid-19, after interim analysis showed the pill lowered the ...

Whichever way you look at it, the Molnupiravir recent scandal stinks in the nostrils of anyone who takes the time to understand the documents made public and the parliamentary and extra-parliamentary ...

A popular antiviral Covid drug used against the disease is driving unexpected mutations in the virus, a leading team of international scientists have warned. Researchers studied a staggering 15 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The antiviral reduced the risk for severe symptoms of ...

A widely used COVID-19 antiviral drug, molnupiravir, has been linked with a pattern of mutations in the SARS-CoV-2 virus, according to a study published in the journal Nature. A team, including ...